U.S. District Judge Roger Benitez retired this month after nearly 22 years in a role for which he was known for issuing harsh sentences and frequently striking down California gun laws. The ...

MANILA, Philippines — In commemoration of World Book Day on April 23, Instituto Cervantes de Manila will bring back its "Día del Libro" event filled with activities dedicated to the love of reading.

Michael J. Fox is alive and well, despite rumors of his death circulating online. One day after CNN ignited a death scare by releasing a video package titled "Remembering the life of actor Michael J.

Michael J. Fox is alive and well, the “Back to the Future” icon assured fans on Threads after CNN sparked a death scare by releasing a video on its content platforms titled “Remembering the life of ...

Another Hollywood heavyweight is pulling up stakes – with hitmaker J.J. Abrams shifting his production empire as Los Angeles continues to hemorrhage entertainment jobs. Abrams, 58, the blockbuster ...

Royalty Pharma has made another play in the autoimmune space, this time crowning Johnson & Johnson as the beneficiary. Royalty and J&J have agreed to co-fund the development of a chronic autoimmune ...

The Cardinals are entering the 2026 season with low expectations, as the plan throughout the offseason was clear in building toward the future. It might not be a radical one, but this is one of the ...

Johnson & Johnson is suing a former oncology medical affairs employee, alleging a massive and “malicious” stealing of trade secrets. According to a complaint filed March 12 in a federal court in New ...

The immediate future of Minnesota Vikings quarterback J.J. McCarthy has been a subject of much debate over the past couple of weeks. Some aren't sold on J.J. being the starter in 2026, while others ...

Romantasy fans have been patiently awaiting a new novel from Sarah J. Maas for years, and the past day has left them with more questions than answers. Fans have been abuzz since Maas' July Instagram ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...